189 related articles for article (PubMed ID: 33811753)
1. Novel HEXA variants in Korean children with Tay-Sachs disease with regression of neurodevelopment from infancy.
Park JH; Ko JM; Kim MS; Kim MJ; Seong MW; Yoo T; Lim BC; Chae JH
Mol Genet Genomic Med; 2021 Jun; 9(6):e1677. PubMed ID: 33811753
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and mutational analyses of HEXA in a cohort of Egyptian patients with infantile Tay-Sachs disease. Expansion of the mutation spectrum.
Ibrahim DMA; Ali OSM; Nasr H; Fateen E; AbdelAleem A
Orphanet J Rare Dis; 2023 Mar; 18(1):52. PubMed ID: 36907859
[TBL] [Abstract][Full Text] [Related]
3. Three novel mutations in Iranian patients with Tay-Sachs disease.
Jamali S; Eskandari N; Aryani O; Salehpour S; Zaman T; Kamalidehghan B; Houshmand M
Iran Biomed J; 2014; 18(2):114-9. PubMed ID: 24518553
[TBL] [Abstract][Full Text] [Related]
4. Tay-Sachs disease in an Arab family due to c.78G>A HEXA nonsense mutation encoding a p.W26X early truncation enzyme peptide.
Haghighi A; Masri A; Kornreich R; Desnick RJ
Mol Genet Metab; 2011 Dec; 104(4):700-2. PubMed ID: 21967858
[TBL] [Abstract][Full Text] [Related]
5. Prenatal Diagnosis of Tay-Sachs Disease.
Zhang J; Chen H; Kornreich R; Yu C
Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel mutations in HEXA gene in children affected with Tay Sachs disease from India.
Mistri M; Tamhankar PM; Sheth F; Sanghavi D; Kondurkar P; Patil S; Idicula-Thomas S; Gupta S; Sheth J
PLoS One; 2012; 7(6):e39122. PubMed ID: 22723944
[TBL] [Abstract][Full Text] [Related]
7. Unusual case of Juvenile Tay-Sachs disease.
Cheema HA; Waheed N; Saeed A
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519716
[TBL] [Abstract][Full Text] [Related]
8. Improving accuracy of Tay Sachs carrier screening of the non-Jewish population: analysis of 34 carriers and six late-onset patients with HEXA enzyme and DNA sequence analysis.
Park NJ; Morgan C; Sharma R; Li Y; Lobo RM; Redman JB; Salazar D; Sun W; Neidich JA; Strom CM
Pediatr Res; 2010 Feb; 67(2):217-20. PubMed ID: 19858779
[TBL] [Abstract][Full Text] [Related]
9. Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease.
Chen Y; Jian J; Hettinghouse A; Zhao X; Setchell KDR; Sun Y; Liu CJ
J Mol Med (Berl); 2018 Dec; 96(12):1359-1373. PubMed ID: 30341570
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel variants in a large cohort of children with Tay-Sachs disease: An initiative of a multicentric task force on lysosomal storage disorders by Government of India.
Mistri M; Mehta S; Solanki D; Kamate M; Gupta N; Kabra M; Puri R; Girisha K; Hariharan S; Nampoothiri S; Sheth F; Sheth J
J Hum Genet; 2019 Oct; 64(10):985-994. PubMed ID: 31388111
[TBL] [Abstract][Full Text] [Related]
11. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease.
Demir SA; Timur ZK; Ateş N; Martínez LA; Seyrantepe V
J Neuroinflammation; 2020 Sep; 17(1):277. PubMed ID: 32951593
[TBL] [Abstract][Full Text] [Related]
12. Identification of deletion-duplication in HEXA gene in five children with Tay-Sachs disease from India.
Sheth J; Mistri M; Mahadevan L; Mehta S; Solanki D; Kamate M; Sheth F
BMC Med Genet; 2018 Jul; 19(1):109. PubMed ID: 29973161
[TBL] [Abstract][Full Text] [Related]
13. A pathogenic HEXA missense variant in wild boars with Tay-Sachs disease.
Bertani V; Prioni S; Di Lecce R; Gazza F; Ragionieri L; Merialdi G; Bonilauri P; Jagannathan V; Grassi S; Cabitta L; Paoli A; Morrone A; Sonnino S; Drögemüller C; Cantoni AM
Mol Genet Metab; 2021 Jul; 133(3):297-306. PubMed ID: 34119419
[TBL] [Abstract][Full Text] [Related]
14. Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease.
Seyrantepe V; Demir SA; Timur ZK; Von Gerichten J; Marsching C; Erdemli E; Oztas E; Takahashi K; Yamaguchi K; Ates N; Dönmez Demir B; Dalkara T; Erich K; Hopf C; Sandhoff R; Miyagi T
Exp Neurol; 2018 Jan; 299(Pt A):26-41. PubMed ID: 28974375
[TBL] [Abstract][Full Text] [Related]
15. GM2 gangliosidoses in Spain: analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients.
Gort L; de Olano N; Macías-Vidal J; Coll MA;
Gene; 2012 Sep; 506(1):25-30. PubMed ID: 22789865
[TBL] [Abstract][Full Text] [Related]
16. Screening for Tay-Sachs disease carriers by full-exon sequencing with novel variant interpretation outperforms enzyme testing in a pan-ethnic cohort.
Cecchi AC; Vengoechea ES; Kaseniit KE; Hardy MW; Kiger LA; Mehta N; Haque IS; Moyer K; Page PZ; Muzzey D; Grinzaid KA
Mol Genet Genomic Med; 2019 Aug; 7(8):e836. PubMed ID: 31293106
[TBL] [Abstract][Full Text] [Related]
17. In-silico screening and microsecond molecular dynamics simulations to identify single point mutations that destabilize β-hexosaminidase A causing Tay-Sachs disease.
Almanasra A; Havranek B; Islam SM
Proteins; 2021 Nov; 89(11):1587-1601. PubMed ID: 34288098
[TBL] [Abstract][Full Text] [Related]
18. Atypical presentation of late-onset Tay-Sachs disease.
Deik A; Saunders-Pullman R
Muscle Nerve; 2014 May; 49(5):768-71. PubMed ID: 24327357
[TBL] [Abstract][Full Text] [Related]
19. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].
Tsuji D
Yakugaku Zasshi; 2013; 133(2):269-74. PubMed ID: 23370522
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
